Palla Pharma Limited chart

Last update: 2021-02-19
Key statistics and financials
Revenue per share 0.12
Dividend & YieldN/A$ (N/A)
Beta 1.07
Market capitalization 47.76M
Operating cash flow -22.69M
ESG Scores unknown

Company description

Palla Pharma Limited, a vertically integrated pharmaceutical company, produces and distributes narcotic raw materials, active pharmaceutical ingredients, and finished dosage formulations for pharmaceutical markets in Australia and Norway. It also produces and distributes poppy seeds to culinary markets. The company was formerly known as TPI Enterprises Limited and changed its name to Palla Pharma Limited in June 2019. Palla Pharma Limited was incorporated in 2004 and is headquartered in Melbourne, Australia.

Sector: Consumer Defensive - Industry: Farm Products

Financial Ratios
Quick Ratio0.6
Working Capital-1.69
Return On Equity-0.96
Debt To Equity0.36
Fixed Asset Ratio0.06
Fixed Interest Cover-15.11

Financial data

Financial Statements

Cashflow Statement 2017-12-31 2018-12-31 2019-12-31 2020-12-31
Change To Liabilities 4.38M 73.29k -1.7M -893.24k
Total Cashflows From Investing Activities -27.95M 2.8M -2.48M 765.81k
Net Borrowings -6.52M 9.64M -17.4M 12.54M
Total Cash From Financing Activities 44.46M 9.64M 11.69M 12.53M
Change To Operating Activities 444.74k -1.03M 1.24M -102.82k
Issuance Of Stock 53.83M 30.98M 30.98M
Net Income -16.69M -5.79M -7.64M -34.76M
Change In Cash 3.02M -1.74M 114.5k -1.41M
Effect Of Exchange Rate -338.78k 466.52k 369.55k 71.26k
Total Cash From Operating Activities -13.14M -14.65M -9.47M -14.78M
Depreciation 2.42M 2.55M 2.51M 2.66M
Change To Account Receivables -5.21M -5.54M -2.03M 10.41M
Other Cashflows From Financing Activities -2.86M -1.89M -1.89M -3.1k
Change To Netincome 198.73k -425.62k 1.55M 12.65M
Capital Expenditures -1.87M -2.78M -1.88M -789.47k

Income Statement 2017-12-31 2018-12-31 2019-12-31 2020-12-31
Research Development 374.98k 268.86k
Income Before Tax -16.69M -6.77M -7.78M -34.76M
Net Income -16.69M -5.79M -7.64M -34.76M
Selling General Administrative 10.69M 15.2M 15.52M 12.5M
Gross Profit 2.09M 15.34M 17.3M -1.15M
Ebit -12.77M -4.59M -2.67M -19.26M
Operating Income -12.77M -4.59M -2.67M -19.26M
Interest Expense -2.02M -1.66M -2.8M -1.27M
Income Tax Expense 134.89k -138.19k
Total Revenue 21.67M 46.46M 54.69M 22.01M
Cost Of Revenue 19.58M 31.12M 37.38M 23.16M
Total Other Income ExpenseNet -3.92M -2.18M -5.11M -15.5M
Net Income From Continuing Ops -16.69M -6.91M -7.64M -34.76M
Net Income Applicable To Common Shares -16.69M -5.79M -7.64M -34.76M

Balance Sheet Statement 2017-12-31 2018-12-31 2019-12-31 2020-12-31
Total Liabilities 23.59M 34.46M 18.16M 31.3M
Total Stockholder Equity 53.25M 49.3M 71.41M 36.12M
Other Current Liabilities 1.7M 1.05M 890.9k 1.44M
Total Assets 76.84M 83.76M 89.57M 67.42M
Common Stock 181.48M 181.48M 211M 210.99M
Other Current Assets 2.96M
Retained Earnings -130.09M -135.54M -143.18M -177.94M
Treasury Stock 1.86M 3.36M 3.6M 3.07M
Cash 3.64M 1.9M 2.02M 609.66k
Total Current Liabilities 23.27M 11.44M 11.22M 16.05M
Other Stockholder Equity 1.86M 3.36M 3.6M 3.07M
Property, Plant, and Equipment 27.39M 27.76M 26.69M 24.27M
Total Current Assets 33.64M 39.25M 43.15M 36.58M
Net Tangible Assets 38.11M 35.25M 55.24M 33.24M
Net Receivables 9.33M 15.46M 17.5M 7.5M
Accounts Payable 6.69M 8.05M 7.04M 7.37M


Insider Transactions

Here are the insider transactions of stock shares related to Palla Pharma Limited:

Filer Name Transaction Text Ownership Date Filer Relation Shares
Ross (Iain)Purchase at price 0.36 per share.D2021-04-12Director (Non-Executive)75k
Black (Stuart Alexander)Other at price 0.38 per share.D2021-03-29Independent Non-Executive Director26.23k
Moore (Simon Colinton)Other at price 0.38 per share.D2021-03-08Independent Non-Executive Chairman13.79k
Ritchie (Jarrod David)D2020-12-22Former1.17k
Black (Stuart Alexander)Other at price 0.48 per share.D2019-11-18Director (Non-Executive)8.77k
Moore (Simon Colinton)Other at price 0.48 per share.D2019-11-18Independent Non-Executive Chairman871.88k
Ritchie (Jarrod David)D2019-11-18Chief Executive Officer580.13k
Ritchie (Jarrod David)D2018-12-31Chief Executive Officer6.05k
Robinson (Peter Raymond)Purchase at price 1.06 per share.D2018-03-02Non Executive Chairman41.98k
Ritchie (Jarrod David)D2017-12-31Managing Director17.8k
Moore (Simon Colinton)D2017-12-31Director (Non-Executive)37k
Ritchie (Jarrod David)D2017-12-12Managing Director1.59M
Black (Stuart Alexander)Purchase at price 1.90 per share.D2017-09-01Director (Non-Executive)15k
Moore (Simon Colinton)Other at price 1.71 per share.D2017-07-17Director (Non-Executive)176.62k
Robinson (Peter Raymond)Other at price 1.65 per share.D2017-04-19Non Executive Chairman16.98k
Moore (Simon Colinton)Other at price 1.68 per share.D2017-03-31Director (Non-Executive)524.14k
McPherson (Roger)D2016-12-31Former10k
Moore (Simon Colinton)Other at price 2.21 per share.D2016-08-05Director (Non-Executive)1.38M
Ritchie (Jarrod David)Purchase at price 2.24 per share.D2016-05-31Managing Director1k
McPherson (Roger)D2015-12-31Chief Financial Officer10k
Ritchie (Jarrod David)Purchase at price 2.45 per share.D2015-10-28Managing Director1.8k
Ritchie (Jarrod David)Purchase at price 2.48 per share.D2015-10-27Managing Director15k
Ritchie (Jarrod David)Purchase at price 2.20 per share.D2015-10-12Managing Director3.33k
Ritchie (Jarrod David)Purchase at price 2.08 per share.D2015-10-12Managing Director36k
Ritchie (Jarrod David)Purchase at price 1.91 per share.D2015-09-04Managing Director4.29k
Ritchie (Jarrod David)Purchase at price 2.07 per share.D2015-09-03Managing Director10k
Robinson (Peter Raymond)Purchase at price 2.10 per share.D2015-09-01Non Executive Chairman34.9k
Ritchie (Jarrod David)Purchase at price 2.38 per share.D2015-08-31Managing Director5.71k

Insider transaction explanations

Insider buying is the legal purchase of shares by a senior executive or director of a company. "Filer Name" corresponds to the name of the stock buyer or seller. "Transaction Text" describes the transaction. "Ownership" gives information about the transaction type. "Date" is the reported transaction date. "Filer Relation" gives the role of the insider in the company. "Shares" is the value of the transaction. You will find the complete description of the General Transaction Codes on the SEC dedicated page


Investment strategy backtesting

These are the result of three automatic investment systems applied to Palla Pharma Limited. You will find the performance of an systematic investment system, a momentum strategy, and a buy the dip trading strategy.


Systematic investment results on Palla Pharma Limited

Here is the result of two systematic investment strategies applied to Palla Pharma Limited. The first strategy automatically buys the first day of the month, and the second strategy buys the fifteenth day of the month.

Systematic investment equity curve on Palla Pharma Limited

The following chart shows the equity curve of the two systematic investment strategies applied to Palla Pharma Limited:

Palla Pharma Limited automated entries

The systematic investment strategy that buys the first day of the month would give a performance of -54.01% on the backtest period.

Performance at glance

Performance

-54.01 %

Latent gain

-1213.62 $

Invested capital

2246.94 $

Annualized return

-12.74 %
Build your Trading System
Automated Trading using Prorealtime ebook

Momentum strategy results on Palla Pharma Limited

This is the result of two momentum investment strategies applied to Palla Pharma Limited. The first strategy uses a momentum signal calculated on one quarter, and the second uses a momentum signal calculated on two quarters.

Momentum entry openings on Palla Pharma Limited

The following chart shows all the entries opened by the momentum investment system on Palla Pharma Limited:

Palla Pharma Limited momentum entries
  • The first momentum investment strategy would give -51.38% of return on Palla Pharma Limited. That represents -2829.24$ of latent gain with 5506.28$ of employed capital.
  • The second momentum investment strategy would give -49.34% of return on Palla Pharma Limited. That represents -1233.5$ of latent gain with 2500.09$ of employed capital.
Performance at glance (1Q Momentum)

Performance

-51.38 %

Latent gain

-2829.24 $

Invested capital

5506.28 $

Annualized return

-11.17 %
Performance at glance (2Q Momentum)

Performance

-49.34 %

Latent gain

-1233.5 $

Invested capital

2500.09 $

Annualized return

-13.12 %

Momentum equity curve on Palla Pharma Limited

The following chart shows the equity curve of the two momentum strategies applied to Palla Pharma Limited:

Palla Pharma Limited momentum equity

Note: the dividends potentially given by Palla Pharma Limited are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on Palla Pharma Limited

The following chart shows the employed capital evolution of the two momentum strategies on Palla Pharma Limited since the beginning:

Palla Pharma Limited

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Buy the dip strategy result on Palla Pharma Limited

Buy the dip entry openings on Palla Pharma Limited

Palla Pharma Limited

The performance achieved by the robo-advisor on Palla Pharma Limited is -25.01%. That represents -312.88$ of latent gain with 1250.83$ of employed capital. The following chart shows Palla Pharma Limited stock price with all the entries opened by the automated investment system.

Note: The blue line represents the weekly stock price of Palla Pharma Limited, and the green triangles represent the entry openings. The artificall robo-advisor needs at least 100 weeks of trading history to work.

Performance at glance

Performance

-25.01 %

Latent gain

-312.88 $

Invested capital

1250.83 $

Annualized return

-11.17 %

Equity curve of the strategy applied to Palla Pharma Limited

The following chart shows the result of the investment strategy applied to Palla Pharma Limited:

Palla Pharma Limited

Note: the dividends potentially given by Palla Pharma Limited are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on Palla Pharma Limited

The following chart shows the employed capital evolution since the beginning of the investment strategy on Palla Pharma Limited:

Palla Pharma Limited

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Investment strategies comparison on Palla Pharma Limited

In this section, I will compare the three previous investment strategies applied to Palla Pharma Limited.

Equity curve comparison on Palla Pharma Limited

The following chart shows the equity curve of the artificall advisor, the trend folowing and the automatic investment strategies:

Palla Pharma Limited investment strategy comparison

Employed capital comparison on Palla Pharma Limited

Palla Pharma Limited investment comparison

Performance comparison on Palla Pharma Limited

Strategy Latent Profit Growth Employed capital CAGR
Automatic investment -54.01% -1213.62$ 2246.94$ -12.74%
Momentum 1 quarter -51.38% -2829.24$ 5506.28$ -12.85%
Momentum 2 quarters -49.34% -1233.5$ 2500.09$ -13.12%
Non-directional -25.01% -312.88$ 1250.83$ -11.17%
Annualized return comparison

Automatic investment

-12.74 %

Momentum 1Q

-13.12 %

Momentum 2Q

-13.12 %

Non-directional

-11.17 %

Correlated stocks

Here are the most positively and negatively correlated stocks with Palla Pharma Limited:

Positive correlations

Most correlated stocks this year


Most correlated stocks last 3 months

Negative correlation

Most negatively correlated stocks this year


Most negatively correlated stocks last 3 months

Note: The algorithm computes the probability of correlation between Palla Pharma Limited and the other stocks. There may be false positives or some missing correlated stocks. If the price of Palla Pharma Limited does not vary for 36 weeks, the correlation calculation result will be wrong.


Company information

Company name Palla Pharma Limited
Country Australia
City Melbourne
Address Tower 4
Phone 61 3 9301 0800
Website www.pallapharma.com
FullTime employees
Industry Farm Products
Sector Consumer Defensive
Exchange XASX
Ticker PAL.XASX
Market www2.asx.com.au

Palla Pharma Limited ESG Scores

Environment scores

Environment ESG Factors Scores
Environment Score 0
Peer Environment Performance unknown
Environment Percentile unknown
Palm Oil unknown
Nuclear unknown
Fur Leather unknown
GMO unknown
Coal unknown
Pesticides unknown
Animal Testing unknown

Social scores

Social ESG Factors Scores
Social Score 0
Peer Social Performance unknown
Social Percentile unknown
Highest Controversy unknown
Peer Highest Controversy Performance unknown
Adult unknown
Gambling unknown
Alcoholic unknown
Tobacco unknown
Catholic unknown
Controversial Weapons unknown
Small Arms unknown
Military Contract unknown
Peer Count unknown

Related Controversy:


Governance scores

Governance ESG Factors Scores
Governance Score 0
Peer Governance Performance unknown
Governance Percentile unknown

ESG at glance
Total ESG Scores: unknown
Environment Score: 0
Social Score: 0
Governance Score: 0

ESG Performance: unknown

Peer Group: unknown

Peer Esg Score Performance: unknown

Rating Year: unknown

Rating Month: unknown

Max Age: unknown

Percentile: unknown